Clinical trial
A Randomized, Double-blind, Active-controlled, Parallel-group, Multicenter, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2001 in Patients With Acute Bronchitis
NCT07198347 is registered in ClinicalTrials.gov with Ahn-Gook Pharmaceuticals Co.,Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Active-controlled, Parallel-group, Multicenter, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2001 in Patients With Acute Bronchitis
- Lead sponsor
- Ahn-Gook Pharmaceuticals Co.,Ltd
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- November 1, 2025
- Completion date
- October 31, 2026
- Enrollment
- 300 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acute bronchitis